Zobrazeno 1 - 10
of 2 308
pro vyhledávání: '"Endrikat, J."'
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 1577-1588 (2024)
Jan Endrikat,1,2 Gilda Schmidt,2 Bhagyashree Oak,3 Viplav Shukla,3 Prakirti Nangia,3 Nicolas Schleyer,1 John Crocker,3 Ruud Pijnapppel4 1Radiology, Bayer AG, Berlin, Germany; 2Department of Gynecology, Obstetrics and Reproductive Medicine, University
Externí odkaz:
https://doaj.org/article/273935df0e884243bae66b83f376800d
Clinical Safety of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations.
Autor:
Endrikat J; From the Bayer AG, Radiology, Berlin, Germany (J.E., L.S., C.H.); Department of Gynecology, Obstetrics, and Reproductive Medicine, University Medical School of Saarland, Homburg/Saar, Germany (J.E.); Department of Diagnostic and Interventional Radiology, University of Leipzig, Heart Center, Leipzig, Germany (M.G.); Department of Neuroradiology, University of Leipzig, Leipzig, Germany (K.-T.H.); Bayer US LLC, Benefit Risk Management Pharmacovigilance, Whippany, NJ (A.B.); and Department of Radiology and Nuclear Medicine, University Hospital Schleswig Holstein-Campus Luebeck, Luebeck, Germany (J.B.)., Gutberlet M, Hoffmann KT, Schöckel L, Bhatti A, Harz C, Barkhausen J
Publikováno v:
Investigative radiology [Invest Radiol] 2024 Sep 01; Vol. 59 (9), pp. 605-613. Date of Electronic Publication: 2024 Mar 01.
Autor:
Endrikat J; Radiology R&D, Bayer AG, 13353 Berlin, Germany.; Department of Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland, 66421 Homburg/Saar, Germany., Ullmann A; Statistics & Data Insights, Bayer AG, Wuppertal, 42113, Germany., Gerlinger C; Department of Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland, 66421 Homburg/Saar, Germany.; Statistics & Data Insights, Bayer AG, Wuppertal, 42113, Germany., Bhatti A; Benefit Risk Management Pharmacovigilance, Bayer US LLC, Whippany NJ 07981, United States., Lengsfeld P; Radiology R&D, Bayer AG, 13353 Berlin, Germany., Michel A; Division Pharmaceuticals, Integrated Evidence Generation, Bayer Consumer Care AG, 4052 Basel, Switzerland.
Publikováno v:
The British journal of radiology [Br J Radiol] 2024 Dec 01; Vol. 97 (1164), pp. 2004-2014.
Autor:
Endrikat J; From the Radiology, Bayer AG, Berlin, Germany (J.E., L.S., C.H.); Department of Gynecology, Obstetrics, and Reproductive Medicine, University Medical School of Saarland, Homburg/Saar, Germany (J.E.); Department of Diagnostic and Interventional Radiology, University of Leipzig, Heart Center, Leipzig, Germany (M.G.); Department of Radiology and Nuclear Medicine, University Hospital Schleswig Holstein-Campus Luebeck, Luebeck, Germany (J.B.); Bayer US LLC, Benefit-Risk Management Pharmacovigilance, Whippany, NJ (A.B.); and Department of Neuroradiology, University of Leipzig, Leipzig, Germany (K.-T.H.)., Gutberlet M, Barkhausen J, Schöckel L, Bhatti A, Harz C, Hoffmann KT
Publikováno v:
Investigative radiology [Invest Radiol] 2024 May 01; Vol. 59 (5), pp. 345-358. Date of Electronic Publication: 2023 Oct 18.
Autor:
Thuering J; Radiology, Bayer AG, Leverkusen, Germany., Endrikat J; Radiology, Bayer AG, Berlin, Germany.
Publikováno v:
Acta radiologica (Stockholm, Sweden : 1987) [Acta Radiol] 2024 Jul; Vol. 65 (7), pp. 869-872. Date of Electronic Publication: 2024 Feb 14.
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 10, Pp 347-352 (2017)
Gerald Staedtler,1 Kaweh Shakery,2 Jan Endrikat,3,4 Richard Nkulikiyinka,2 Christoph Gerlinger1,4 1Bayer AG, Pharmaceutical Statistics, 2Bayer AG, Dermatology & Anti-infectives 2, 3Bayer AG, Radiology, Berlin, 4Department of Gynecology, Obstetrics an
Externí odkaz:
https://doaj.org/article/f9c704de53c448638a8fc505c0c08e92
Publikováno v:
In Clinical Radiology July 2015 70(7):743-751
Publikováno v:
Journal of Business Ethics, 2015 Jan 01. 126(2), 185-204.
Externí odkaz:
http://www.jstor.org/stable/24702742
Autor:
Endrikat J; Radiology R&D, Bayer AG, Berlin, Germany.; Department of Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland, Homburg, Germany., Khater H; Radiology R&D, Bayer AG, Berlin, Germany., Boreham AD; Co.medical, Berlin, Germany., Fritze S; Medical Affairs & Pharmacovigilance, Pharmaceuticals, Product Information, Bayer AG, Berlin, Germany., Schwenke C; SCO: SSiS, Minden, Germany., Bhatti A; Benefit Risk Management Pharmacovigilance, Bayer US LLC, Whippany, NJ, USA., Trnkova ZJ; Radiology R&D, Bayer AG, Berlin, Germany., Seidensticker P; Radiology Global Medical Affairs, Bayer AG, Pittsburgh, PA, USA.
Publikováno v:
Breast cancer : basic and clinical research [Breast Cancer (Auckl)] 2023 Aug 16; Vol. 17, pp. 11782234231189467. Date of Electronic Publication: 2023 Aug 16 (Print Publication: 2023).
Autor:
Endrikat J, Chernova J; Bayer AG, Statistics & Data Insights., Gerlinger C, Pracz M; Bayer AG, Statistics & Data Insights., Lengsfeld P; From the Bayer AG, Radiology R&D, Berlin., Bhatti A; Bayer US LLC, Benefit Risk Management Pharmacovigilance., Michel A; Bayer Consumer Care AG, Division Pharmaceuticals, Integrated Evidence Generation, Basel, Switzerland.
Publikováno v:
Investigative radiology [Invest Radiol] 2022 May 01; Vol. 57 (5), pp. 318-326.